View Clinical Trial (Medical Research Study)
Type II Diabetes - Omaha NE (Clinical Trial 6989)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.
| City: |
|
Omaha |
| State: |
|
NE |
| Zip Code: |
|
68114 |
| Study summary: |
|
A multicenter, randomized, double-blind, placebo-controlled study to determine the efficacy and safety of Alogliptin plus Metformin, Alogliptin alone, or Metformin alone in subjects with Type II Diabetes. |
| Qualified participants must: |
|
• Be 19 years of age or older
•
Have Type II Diabetes
•
Currently not taking any diabetic medication
|
| Participants will receive: |
|
Study medication, physical exams, and lab work at no cost. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.